Can you tell me when apotex's ruxolitinib received approval?

I’m not sure which market you mean. Apotex could have a generic version of ruxolitinib approved in the US, Canada, EU, etc., and the date would be different for each regulator.

Could you tell me:
- Which jurisdiction (US, Canada, EU, or another country)?
- Do you mean Apotex’s generic ruxolitinib approval for US market (ANDA), or another product/market?

If you’d like, I can look up the exact date for the specific regulator you have in mind and tell you the approval date from the official record (e.g., FDA Orange Book for the US, Health Canada Drug Product Database for Canada, EMA for the EU).